Flexible Ureteroscopy
Flexible Ureteroscope Care and Maintenance
Maximize your service life and protect your investment by following these basic tips concerning setup, cleaning, and transport of your flexible ureteroscope. Proper care can help lower your total cost of ownership.
Flexible Ureteroscope for Acute Angled Calices
Reach stones others can't. The Flex-Xc is the ONLY digital ureteroscope to reach stones in acutely angled calices. The extreme deflection and superior image quality sets a new level in effective stone treatment.
Mini-PCNL
Minimally Invasive PCNL Technique and Demo
Minimally Invasive PCNL (MIP) is more than a mini-perc. This system takes advantage of single-step dilation and the vacuum effect to remove stones with minimal trauma and faster procedure times. Send your patients home stone-free with just a Band-aid!
Minimally Invasive PCNL Surgery Technique
Minimally invasive percutaneous nephrolithotomy for stone removal offers advantages for surgeon and patient alike. Using a live case study, this 14-min. video explains the whole procedure, from equipment to technique.
Renal Access for PCNL: Step-by-Step Guide
This 18-min. instructional video provides a step-by-step guide to renal access for percutaneous nephrolithotomy. It was prepared by Julio Davalos, MD, of Chesapeake Urology Associates and the University of Maryland.
UH 400
Surgical Generator for Bipolar Resection
The UH 400 surgical generator provides high-frequency current for endoscopic cutting, coagulation, and dissection. Pair it with our true bipolar electrodes, designed to deliver maximum control with minimal energy.
Bipolar Electrodes for Urology Surgery
Our true bipolar electrodes come in various styles to meet diverse surgical needs. Watch how precisely they perform during endoscopic bladder dome and posterior wall resections, treatment of papillary lesions, and more.
HD-VIEW™
High-Definition Flexible Video Cystoscope
HD-VIEW™ sets a whole new standard, with its tapered tip, large working channel, and optional suction feature. HD-VIEW™ sets a whole new standard, with its tapered tip, large working channel, and optional suction feature. See the Difference...
KARL STORZ Blue Light Cystoscopy with Cysview® System Brochure*
Blue-light cystoscopy with Cysview® is the only FDA-approved technology for enhanced detection of bladder cancer, turning tumors bright pink during surgery. Pair it with our UH 400 surgical generator for optimal results.
Blue Light Cystoscopy Clinical Advantages
Thomas Cangiano, MD, Board-certified urologist at AdventHealth Altamonte Springs, FL, describes his initial experiences and observations using Blue Light Cystoscopy with Cysview® (BLCC) on his patients.
Blue Light Cystoscopy Patient Case Study
At 28 years old, Mary Beth Ballard received a bladder cancer diagnosis that would change her life. Doctors at Vanderbilt University Medical Center were able to treat her using blue-light cystoscopy. This is her story.
Using KARL STORZ Blue Light Cystoscopy with Cysview
Blue Light Cystoscopy with Cysview® is the only FDA-approved technology for enhanced detection of bladder cancer. Use flexible cystoscopy for ongoing surveillance, and rigid cystoscopy for resection. Learn more here.
Ultrasound Guidance for Mini PCNL
Fluoro-guided access is still the norm for minimally invasive PCNL. Is ultrasound a better option? In this master class, Dr. Roger Sur from UC San Diego shares his experience using ultrasound, with practical tips for success.
Mini PCNL Instrumentation and Demo
Dr. Seth Bechis of UC San Diego introduces the reusable instrument set needed to perform minimally invasive PCNL on an outpatient basis and demonstrates procedural steps, including the vacuum effect.
Minimally Invasive PCNL vs. Ureteroscopy
Dr. Sri Sivalingam of the Cleveland Clinic compares minimally invasive PCNL and ureteroscopy, especially for treating stones from 1 to 2 cm. Stone-free rates, bleeding risk, ergonomics, and tubeless options are discussed.
Mini PCNL in the Outpatient Setting
Is minimally invasive PCNL suitable for outpatient settings? In this master class, Dr. Julio Davalos of Chesapeake Urology gives practical tips and considerations for transitioning MIP cases from the hospital to the ASC.
Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer.
Anaphylactoid shock, hypersensitivity reactions, bladder pain, cystitis, and abnormal urinalysis have been reported after administration of Cysview. The most common adverse reactions seen in clinical trials were bladder spasm, dysuria, hematuria, and bladder pain.
Cysview should not be used in patients with porphyria, gross hematuria, or with known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid. Cysview may fail to detect some malignant lesions. False positive fluorescence may occur due to inflammation, cystoscopic trauma, scar tissue, previous bladder biopsy and recent BCG therapy or intravesical chemotherapy. No specific drug interaction studies have been performed.
Safety and effectiveness have not been established in pediatric patients. There are no available data on Cysview use in pregnant women. Adequate reproductive and developmental toxicity studies in animals have not been performed. Systemic absorption following administration of Cysview is expected to be minimal. There are no data on the presence of hexaminolevulinate in human or animal milk, the effects on a breastfed infant, or the effects on milk production. The development and health benefits of breastfeeding should be considered along with the mother’s clinical need for Cysview and any potential adverse effects on the breastfed infant from Cysview or from the underlying maternal condition.
Cysview is approved for use with the KARL STORZ D-Light C Photodynamic Diagnostic (PDD) system. For system set up and general information for the safe use of the PDD system, please refer to the KARL STORZ instruction manuals for each of the components.
Prior to Cysview administration, read the Full Prescribing Information and follow the preparation and reconstitution instructions.
Cysview is an optical imaging agent indicated for use in the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for carcinoma of the bladder. Cysview is used with the KARL STORZ D-Light C Photodynamic Diagnostic (PDD) system to perform Blue Light Cystoscopy (BLCTM) as an adjunct to the white light cystoscopy.
Here to Help
As a leader in minimally invasive surgical devices, KARL STORZ offers complete urology solutions that combine sophisticated telescopes and advanced precision instruments.
Flagship products include high-frequency surgical devices, components for laser surgery, lithotripsy devices for stone detection and removal, rigid and flexible telescopes for procedures in the ureter, flexible video endoscopes, and specialized equipment for photodynamic diagnostics. Our extensive product line includes instruments specifically designed for pediatric patients.
The products described in the videos, images, and documents on this site have been approved authorized by the company for use in the United States only. The materials on this site are provided exclusively as an educational service for medical professionals and do not necessarily reflect the views of KARL STORZ Endoscopy-America, Inc. The decision to apply any of the information on this site is at the sole discretion and choice of qualified medical personnel, who are advised to verify the applicability and the suitability for any particular situation. KARL STORZ cannot be held is not responsible for the misuse of any information on this site.